Anaphylaxis

Current Opinion in Critical Care

Volumn 18, Issue 4, 2012, Pages 308-317

  De Bisschop, Marie Bénédicte ^a,b   Bellou, Abdelouahab ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

anaphylaxis; definition; management; pathophysiology

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT; GLUCAGON; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROCORTISONE; METHYLPREDNISOLONE; SALBUTAMOL; STEROID;

ANAPHYLAXIS; ANXIETY; BRONCHOSPASM; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CRYSTALLOID; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; EARLY DIAGNOSIS; EMERGENCY WARD; HEADACHE; HEART PALPITATION; HUMAN; IMMUNOPATHOGENESIS; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; PALLOR; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RHINORRHEA; RISK FACTOR; SIDE EFFECT; URTICARIA;

ALLERGENS; ANAPHYLAXIS; BRONCHODILATOR AGENTS; EPINEPHRINE; FRANCE; HISTAMINE H1 ANTAGONISTS; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 84863829165     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283557a63     Document Type: Review

References (62)

1. Patel D. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. Value Health 2011; 14:A138.
2. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011; 41:923-938.
3. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review. J Allergy Clin Immunol 2010; 125:1098-1104.
4. Simons FE, Ardusso LR, Bilo B, et al. World Allergy Organization guidelines for assessment and management of anaphylaxis. WAO J 2011; 4:13-37.
5. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010; 125:S161-S181.
6. Soar J, Perkins G, Abbas G, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81:1414-1417.
7. Da Broi U,Moreschi C. Postmortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int 2011; 204:1-5.
8. Lieberman P, Nicklas R,Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126:477-480.
9. Park HJ, Kim SH. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012. [Epub ahead of print]
10. Lieberman P, Ewan P. Anaphylaxis. Allergy 2012. 4th ed. pp. 331-346.
11. Mertes PM, Alla F, Trechot P, et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128:366-373.
12. Garvey L, Belhage B, Krigaard M, et al. Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark. Anesthesiology 2011; 115:111-116.
13. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21:442-453.
14. Arroabarren E, Lasa EM, Olaciregui L, et al. Improving anaphylaxis management in a pediatric emergency department. Pediatr Allergy Immunol 2011; 22:708-714.
15. Rudders S, Banerji A, Corel B, et al. Multicenter study of repeat epinephrine treatments for food related anaphylaxis. Pediatrics 2010; 125:711-718.
16. Calvani M, Cardinale F, Martelli A, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22:813-819.
17. Kanthala AR, Decker WW, Hagan JB, et al. Retrospective validation of the NIAID/FAAN criteria for the diagnosis of anaphylaxis in emergency department patients. Ann Emerg Med 2010; 56:S37.
18. Campbell R, Hagan JB, Manivannan V, et al. Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol 2012; 129:748-752.
19. Campbell R, Hagan J, Li J, et al. Anaphylaxis in emergency department patients 50 or 65 years or older. Ann Allergy Asthma Immunol 2011; 106:401-406.
20. Bellou A, Manel J, Samman-Kaakagi H, et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one years experience. Emerg Med 2003; 15:341-347.
21. Klein JS, Yocum MW. Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 1995; 95:637-638.
22. Schwartz HJ. Acute allergic disease in a hospital emergency room: a retrospective evaluation of one years experience. Allergy Proc 1995; 16:247-250.
23. Stewart AG, Ewan PW. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. Q J Med 1996; 89:859-864.
24. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108:861-866.
25. Pastorello EA, Rivolta F, Bianchi M, et al. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001; 25:11-17.
26. Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371-376.
27. Clark S, Bock SA, Gaeta TJ, et al. Multicenter study of emergency visits for food allergy. J Allergy Clin Immunol 2004; 113:347-352.
28. Clark S, Long AA, Gaeta TJ, Camargo CA. Multicenter study of emergency visits for insect sting allergies. J Allergy Clin Immunol 2005; 116:643-649.
29. De Villiers S, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005; 28:381-388.
30. Braganza SC, Acworth JP, Mckinnon DRL, et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91:159-163.
31. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions 1993 to 2004. Ann Allergy Asthma Immunol 2007; 98:360-365.
32. Ross MP, Ferguson M, Street D, et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 2008; 121:166-171.
33. De Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008; 63:1071-1076.
34. Melville N, Beattie T. Paediatric allergic reactions in the emergency department: a review. Emerg Med J 2008; 25:655-658.
35. Sampson A, Munoz-Furlong A, Campbell R, et al. Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006; 47:373-380.
36. Boyce JA, Assaad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAIDsponsored expert panel. J Allergy Clin Immunol 2010; 126:S1-S58.
37. Longrois D, Lejus C, Constant I, et al. Treatment of hypersensitivity reactions and anaphylactic shock occurring during anesthesia. Ann Fr Anesth Reanim 2011; 30:312-322.
38. Khan B, Kemp S. Pathophysiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2011; 11:319-325.
39. Jönsson F, Mancardi D, Kita Y, et al. Mouse and human neutrophils induce anaphylaxis. J Clin Invest 2011; 121:1484-1496.
40. Li Z, Liang Y, Tang H, et al. Effect of anaphylactic shock on suppressors of cytokine signaling. Immunol Invest 2010; 39:740-753.
41. Laroche D, Debaene B. How to relate the observed event to anaphylaxis? Practice of diagnostic investigations. Ann Fr Anesth Reanim 2011; 30:280-293.
42. Evora P, Simon M. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol 2007; 99:306-313.
43. Salmaan K, Chant C. Allergic and hypersensitivity reactions in the intensive care unit. Crit Care Med 2010; 38:S162-S168.
44. Bellou A, Lambert H, Gillois P, et al. Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown Norway rats anaphylactic shock. Shock 2003; 19:71-78.
45. Cauwels A, Janssen B, Buys E, et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 2006; 116:2244-2251.
46. Sade K, Schwartz IF, Etkin S, et al. Expression of inducible nitric oxide synthase in a mouse model of anaphylaxis. J Investig Allergol Clin Immunol 2007; 17:379-385.
47. Jang D, Nelson L, Hoffman R. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med 2011; 58:565-567.
48. Failli P, Nistri S, Quattrone S, et al. Relaxin up-regulates inducible nitric oxide synthase. FASEB J 2002; 16:252-254.
49. Masini E, Zagli G, Ndisang JF, et al. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway. Br J Pharmacol 2002; 137:337-344.
50. Baccari MC, Bani D. Relaxin and nitric oxide signalling. Curr Protein Pept Sci 2008; 9:638-645.
51. Ahrens R, Osterfeld H, Wu C, et al. Intestinal Mast cell levels control severity of oral antigen-induced anaphylaxis in mice. Am J Pathol 2012; 180:1535-1546.
52. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257:116-128.
53. Dewachter P, Jouan-Hureaux V, Franck P, et al. A form of distributive shock without inhibition of oxygen consumption. Anesthesiology 2005; 103:40-49
54. Jacobsen RC, Millin MG. The use of epinephrine for out-of-hospital treatment of anaphylaxis: resource document for the National Association of EMS Physicians position statement. Prehosp Emerg Care 2011; 15:570-576.
55. Dewachter P, Raëth-Fries I, Jouan-Hureaux V, et al. A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 2007; 106:977-983.
56. Sheikh A, Shehata Y, Brown S, Simons FE. Epinephrine for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2008; (4):CD006312.
57. Jui Lin Choo K, Simons R, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev 2012; 4:CD007596.
58. Sheikh A, Ten Broek V, Brown S, Simons FE. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007; (1):CD006160.
59. El-Agamy S. Antiallergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions. Eur J Pharmacol 2012; 680:115-121.
60. Kawano T, Tamura T, Hamaguchi M, et al. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth 2012; 24:62-64.
61. McDonell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106:199-201.
62. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66:217-219.